What is Autoimmune Hypophysitis?
Autoimmune hypophysitis is an inflammatory condition of the pituitary gland caused by immune-mediated attack, resulting in pituitary enlargement and varying degrees of hypopituitarism (hormone deficiencies). 1, 2
Definition and Pathophysiology
Autoimmune hypophysitis, also called lymphocytic hypophysitis, occurs when inflammatory cells infiltrate the pituitary tissue, leading to:
- Initial pituitary enlargement from infiltration and edema
- Progressive destruction of hormone-producing cells
- Eventual gland atrophy with fibrotic replacement
- Various degrees of permanent pituitary dysfunction 3
The autoimmune process is evidenced by circulating antipituitary antibodies (APA), though these have low diagnostic sensitivity and specificity, limiting their clinical utility. Target autoantigens include alpha-enolase, gamma-enolase, pituitary gland specific factors (PGSF) 1 and 2, and TPIT 3.
Clinical Presentation
Primary Autoimmune Hypophysitis
The classic form predominantly affects women (6:1 ratio for anterior pituitary involvement), with 57% of cases presenting during pregnancy or postpartum 4. It has a prevalence of approximately 5 per million and represents 0.5% of hypopituitarism cases and 2% of nonfunctioning pituitary macroadenomas 4.
Common symptoms include:
- Headache (85% of cases)
- Fatigue (66% of cases)
- Visual disturbances (less common) 5
Immunotherapy-Induced Hypophysitis
With immune checkpoint inhibitors (particularly anti-CTLA-4 antibodies like ipilimumab), hypophysitis has become increasingly recognized 5, 6:
- Incidence: ≤10% with ipilimumab 3 mg/kg, up to 17% at 10 mg/kg
- Incidence: ≤13% with combination ipilimumab/nivolumab
- Median onset: 8-9 weeks after starting treatment (typically after third dose) 5
Hormonal Deficiency Pattern
The characteristic pattern differs from typical pituitary tumors 5:
- Central hypothyroidism (>90% of cases) - most common
- Central adrenal insufficiency (>75% of cases)
- Hypogonadotropic hypogonadism
- Approximately 50% present with panhypopituitarism (all three deficiencies)
- Prolactin deficiency or paradoxical hyperprolactinemia may occur
Biochemical hallmark: Low TSH with low free T4 (central pattern), distinguishing it from primary thyroid disease 5.
Imaging Characteristics
MRI findings that distinguish hypophysitis from pituitary adenomas 5, 4:
- Symmetrical and homogeneous enlargement
- Thickened but undisplaced pituitary stalk
- Suprasellar convexity
- Heterogeneous enhancement
- Increased gland height compared to baseline
Important: Pituitary enlargement can precede clinical symptoms and typically resolves within 2 months, though hormonal deficiencies often persist 5.
Associated Conditions
18% of patients have concurrent autoimmune diseases 4, most commonly:
- Hashimoto's thyroiditis (most frequent association)
- Systemic lupus erythematosus
- IgG4-related disease
- Rheumatoid arthritis (rare) 7
Diagnostic Approach
Definitive diagnosis requires pituitary biopsy, but a presumptive diagnosis can be made based on 5, 4:
Proposed diagnostic criteria:
- ≥1 pituitary hormone deficiency (TSH or ACTH deficiency required) + MRI abnormality, OR
- ≥2 pituitary hormone deficiencies (TSH or ACTH deficiency required) + headache/symptoms
Critical caveat: Biopsy is not always clinically necessary for management and should be reserved for cases where diagnosis significantly impacts treatment decisions or when mass effect requires surgical decompression 4, 8.
Clinical Subtypes
Three anatomical patterns exist 4:
- Anterior pituitary alone (65%) - 6:1 female predominance
- Anterior and posterior pituitary (25%) - 2:1 female predominance
- Neurohypophysis alone (10%) - equal sex distribution
Long-term Implications
Most patients require lifelong hormone replacement 5:
- Adrenal insufficiency and hypothyroidism typically permanent
- Only 15/92 patients in one systematic review achieved full pituitary function recovery 9
- All patients with adrenal insufficiency must carry medical alert identification 5
Critical management principle: When both adrenal insufficiency and hypothyroidism are present, always start steroids before thyroid hormone replacement to avoid precipitating adrenal crisis 5.